Six firms get licence to make crucial HIV injectable

Mitchell commended the speed with which Gilead is moving to make lecapavir accessible to people who need it.

Mitchell Warren, the executive director of AVAC, a non-government organization involved in the HIV fight, said although the granting of licences to generic manufactures is good, it is not enough if some countries are left out. (Courtesy Photo)